Navigation Links
The Leukemia & Lymphoma Society Issues Statement Regarding the Status of Iclusig (Ponatinib)
Date:11/1/2013

WHITE PLAINS, N.Y., Nov. 1, 2013 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) is aware of the FDA's decision requesting Ariad Pharmaceuticals to suspend marketing and sales of Iclusig (ponatinib), a therapy for chronic myeloid leukemia (CML).  As suggested by the FDA, LLS encourages all patients currently receiving ponatinib to speak with their physician to discuss the risk and benefits of continuing treatment with the drug.  Those patients who are responding well to ponatinib, and who are not eligible for therapeutic alternatives, may be able to obtain ponatinib on a compassionate use basis, but need to speak with their oncologists immediately.

We are here to advise patients how the recent news applies to them and what discussions to have with their physicians.  Patients can contact LLS's Information Resource Center at 1-800-955-4572, Monday through Friday from 9 a.m. to 6 p.m. ET.

LLS recognizes the need and urgency for new treatments for CML.  In 2013, we committed $1.7 million to CML research ranging from basic science to clinical research on how best to use new therapies.

"The Leukemia & Lymphoma Society exists to find cures and ensure access to treatments for blood cancer patients," said Mark Velleca, MD, PhD, chief policy and advocacy officer for LLS.  "As such, we felt it was important to comment on this important access issue.  Working with CML physicians and other advocacy groups, we have requested that FDA facilitate continued access to ponatinib for certain patients – such as those in blast crisis – for whom interruption of therapy could be extremely detrimental."

About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, multiple myeloma, a
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. The Leukemia & Lymphoma Society and the Knight Cancer Institute Launch Groundbreaking Collaboration to Improve Outcomes for Acute Myeloid Leukemia Patients
2. OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2017
3. St. Jude Childrens Research Hospital study yields new strategy against high-risk leukemia
4. The Leukemia & Lymphoma Society Co-Pay Assistance Fund Surpasses $200 Million
5. Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine
6. Celebrating 25 Years and Counting: Leukemia and Lymphoma Societys "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients
7. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
8. The Leukemia & Lymphoma Society and Dana-Farber Cancer Institute to Bring Clinical Trials to Local Communities
9. The Leukemia & Lymphoma Society Applauds FDAs Approval of Lenalidomide for Patients with Relapsed or Refractory Mantle Cell Lymphoma
10. The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients
11. Leading Leukemia Experts: High Leukemia Treatment Costs May Be Harming Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 28, 2015  Zipnosis, the first virtual care solution to ... launch their own branded virtual care service line, announced an ... CareNow is currently in use. ... As health ... recognize the value of providing their own branded online care ...
(Date:7/28/2015)... , July 28, 2015  Xencor, Inc. (NASDAQ: ... antibodies for the treatment of autoimmune diseases, asthma and ... second quarter 2015 financial results after the market closes ... a webcast and conference call the same day at ... financial results and provide a corporate update. ...
(Date:7/28/2015)... 28, 2015 Dipexium Pharmaceuticals, Inc. (NASDAQ: ... on the development and commercialization of Locilex® (pexiganan ... data will be presented at the American Society ... Chemotherapy and International Society of Chemotherapy,s International Congress ... in San Diego, California , ...
Breaking Medicine Technology:Zipnosis Announces Group Health to use Virtual Care Service Line 2Zipnosis Announces Group Health to use Virtual Care Service Line 3Xencor to Host Second Quarter 2015 Financial Results Webcast and Conference Call on August 4, 2015 2Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 2Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 3
(Date:7/28/2015)... ... 28, 2015 , ... Santa Rosa’s The Press Democrat announced its annual report of the very ... and Dr. Heather Furnas took the top spot as the Best Cosmetic Surgeons in ... are proud to be bestowed such a prestigious title. , The Press Democrat ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... Miriam Hospital examines outcomes for inmates who continued methadone maintenance treatment (MMT) during ... was more likely to relapse to opiate use (1) and more likely to ...
(Date:7/28/2015)... ... ... Morristown Medical Center, part of Atlantic Health System, today announced it was ... the nation, to implant the newly approved CoreValve® Evolut® R System from Medtronic. The ... condition. , The CoreValve® Evolut® R System was approved by the U.S. Food and ...
(Date:7/28/2015)... Francisco, California (PRWEB) , ... July 28, 2015 , ... ... the results from a recent survey (1) examining consumers’ perspectives on digital ... June 17-24, 2015, covered topics such as innovations in digital health, level of trust ...
(Date:7/28/2015)... ... 2015 , ... Dr. Aziz Ahmad recently gave a talk on the current ... 1 p.m. Tuesday, June 23, at the Gulf Coast Regional Medical Center Large HR ... in colorectal surgery and has more than 35 years of experience in the surgical ...
Breaking Medicine News(10 mins):Health News:Dr. Canales and Dr. Furnas Honored as Sonoma County’s Best Cosmetic Surgeons 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5Health News:Dr. Aziz Ahmad Delivers Talk at Gulf Coast Medical Center 2
... injuries, death while walking or driving , , THURSDAY, Aug. ... an obvious safety concern. But the American College of ... at inappropriate times -- such as when crossing streets ... Teens and young adults, in particular, "are arriving in ...
... Neuron Development to the Foundation,s,Efforts on Behalf of People ... Aug. 21 The Christopher,and Dana Reeve Foundation today ... on Spinal Cord Injury to include a focus on ... L. Pfaff, Ph.D., of The,Salk Institute, who has demonstrated ...
... Health Plan,announced today that it has been awarded an ... Assurance (NCQA), an,independent, non-profit organization that assesses and reports ... Care,s Accreditation,status - the highest possible level - is ... ensures that its members are receiving high quality care., ...
... 21 Fairview and,Blue Cross and Blue Shield of ... Fairview clinics to remain as participating providers,in all of ... to expire at midnight on Friday, August 22, 2008. ... as participating network,hospitals with the Blue Cross network. The ...
... Fla., Aug. 21 SinoFresh HealthCare,Inc. (OTC Bulletin ... respiratory system therapies, today announced that the company,s ... on WallSt.net,s,3-Minute Press Show., The interview gives ... of the company,s latest press release., ...
... universal vaccine effective against several strains of influenza ... Dr. Christine Turley of the University of Texas at ... and clinical research at the Sealy Center for Vaccine ... that VaxInnate,s M2e universal vaccine could possibly protect against ...
Cached Medicine News:Health News:Text-Messaging Injuries Blamed on Distraction 2Health News:Reeve Foundation Recruits Distinguished Stem-Cell Neurobiologist - The Salk Institute's Samuel L. Pfaff, Ph.D. - to its International Research Consortium 2Health News:Reeve Foundation Recruits Distinguished Stem-Cell Neurobiologist - The Salk Institute's Samuel L. Pfaff, Ph.D. - to its International Research Consortium 3Health News:NCQA Awards L.A. Care Health Plan Its Highest Accreditation Status of Excellent 2Health News:[video] Charles Fust, CEO of SinoFresh HealthCare, Inc. Discusses Preliminary Test Results From In Vivo Pilot Study on WallSt.net's 3-Minute Press Show 2
Katena ophthalmic burr for polishing pterygiums, includes one round diamond burr and has an storage case....
... Marco 35-6 TW full diameter trial lens ... for over twenty years. While maintaining only ... manufacturing process, the Marco 35-6 TW trial ... for excellence by adhering to strict industry ...
Khosla Mini Non-Illuminated Trial Lens Set, With Lenses Mounted...
Non-Illuminated Trial Lens Set is an attractive set of trial lenses worked to a high standard of accuracy....
Medicine Products: